Skip to main content

Table 2 Prevalence of Bifidobacterium group and species in faeces and duodenal biopsies of children

From: Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease

Microbial group in biopsy samples

Prevalence (%)a

P-value Chi-square test Bonferroni adjustment

 

Active CD (n = 25)

Non-active CD (n = 8)

Control (n = 8)

Active- non-active CD

Control- active CD

Control- non-active CD

Bifidobacterium group

100.0 (25/25)

100.0 (8/8)

100.0 (8/8)

-

-

-

B. longum

100.0 (25/25)

100.0 (8/8)

100.0 (8/8)

-

-

-

B. breve

64.0 (16/25)

37.5 (3/8)

37.5 (3/8)

0.181

0.181

0.695

B. bifidum

52.0 (13/25)

25.0 (2/8)

37.5 (3/8)

0.180

0.380

0.500

B. adolescentis

36.0 (9/25)

12.5 (1/8)

25.0 (2/8)

0.380

0.669

0.500

B. catenulatum group

52.0 (13/25)

37.5 (3/8)

87.5 (7/8)

0.381

0.050*

0.038*

B. angulatum

32.0 (8/25)

12.5 (1/8)

50.0 (4/8)

0.277

0.419

0.282

B. lactis

60.0 (15/25)

0.0 (0/8)

62.5 (5/8)

0.003*, i

0.618

0.012*, i

B. longum subsp. infantis

0.0 (0/25)

0.0 (0/8)

0.0 (0/8)

-

-

-

B. dentium

8.0 (2/25)

12.5 (1/8)

0.0 (0/8)

0.578

0.568

0.500

Microbial group in faecal samples

Prevalence (%)a

P-value Chi-square test Bonferroni adjustment

 

Active CD (n = 30)

Non-active CD (n = 18)

Control (n = 30)

Active- non-active CD

Control- active CD

Control- non-active CD

Bifidobacterium group

100.0 (30/30)

100.0 (18/18)

100.0 (30/30)

-

-

-

B. longum

100.0 (30/30)

100.0 (18/18)

100.0 (30/30)

-

-

-

B. breve

80.0 (24/30)

66.7 (12/18)

66.7 (20/30)

0.325

0.500

0.751

B. bifidum

100.0 (30/30)

100.0 (18/18)

100.0 (30/30)

-

-

-

B. adolescentis

50.0 (15/30)

83.3 (15/18)

40.0 (12/30)

0.016*, i

0.452

0.045*

B. catenulatum group

100.0 (30/30)

100.0 (18/18)

100.0 (30/30)

-

-

-

B. angulatum

20.0 (6/30)

16.7 (3/18)

23.0 (7/30)

0.546

0.601

0.521

B. lactis

56.7 (17/30)

61.1 (11/18)

63.3 (19/30)

0.502

0.975

0.775

B. longum subsp. infantis

36.7 (11/30)

22.2 (4/18)

36.7 (11/30)

0.351

0.795

0.532

B. dentium

13.3 (4/30)

27.7 (5/18)

6.6 (2/30)

0.265

0.407

0.040*

  1. a Prevalence (Pr) reflects the number of positive amplifications from total samples analysed by PCR (n = number of samples analysed)
  2. * Statistical differences were calculated by using Chi-square test 2 × 2. Significantly difference between groups was consider at P < 0.050
  3. i Statistical differences were corrected for a multiple comparison test (3 variable) by using Bonferroni adjustment. Significantly difference between groups was considered at P < 0.017.